Article
[GWAS-based polygenic risk scores for depression with clinical validation: methods and study design in the Russian population].
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova - 1 Jan 2020
Kibitov A O, Mazo G E, Rakitko A S, Kasyanov E D, Rukavishnikov G V, Ilinsky V V, Golimbet V E, Shmukler A B, Neznanov N G
Abstract excerpt
Depression is one of the leading causes of decreased quality of life and social functioning of patients. In the context of preventive medicine, the prevention of depression becomes a priority. To achieve the goals of prevention, it is necessary to identify specific population risk groups - individuals with a high genetic risk of depression. The paper describes the project aimed at developing a genetic test system...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
